Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 single-arm study of FF-31501 in meniscus tear
jRCT2073220083Phase 3Active, not recruiting
- Sponsor
- FUJIFILM Toyama Chemical
- Start
- Jan 2023
- Modality
- Mesenchymal Stem Cells → Adult Stem Cells → Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of FF-31501 in meniscal tear, sponsored by FUJIFILM Toyama Chemical. Primary endpoint: Change in Lysholm score. Started Jan 2023; status: active, not recruiting.
02
Drugs
FF-31501
03
Conditions
meniscal tear
Beyond the preview
Go deeper on jRCT2073220083.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2073220083.